grant

Targeting pan-drug resistant (PDR) Gram-negative pathogens with novel antisense drug technology [ 2019 - ]

Also known as: 5302231

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/GNT1158171]

Researchers: Dr Nitin Patil (Principal investigator)

Brief description This project aims to address the urgent global health issue of antimicrobial resistance through the discovery and development of innovative new drug technology that restores the activity of our existing antibiotics drugs, that bacterial ‘superbugs’ have developed resistance against. This drug technology will shut down bacterial resistance mechanisms at the genetic level, making antibiotic drugs effective again.

Funding Amount $327,192.00

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857